课题基金 / 基金详情

Signaling through integrin alpha IIb beta3

Signaling through integrin alpha IIb beta3
通过整合素 α IIb beta3 发出信号
批准号:
09671112
负责人:
TOMIYAMA Yoshiaki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

TOMIYAMA Yoshiaki的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究项目中,我们研究了整合素α IIb β 3的由内而外和由外而外的信号传导。关于α IIb β 3通过由内而外信号传导的激活,我们进一步研究了我们的假设,即Na^+/Ca^2+交换器(NCX)可能作为一种常见的由内而外信号传导参与。我们克隆了血小板NCX cDNA,表明血小板NCX是BD型,而心脏NCX是BCDEF型。接下来,使用两种不相关的NCX抑制剂DCB和苄普地尔,我们详细研究了NCX在血小板活化中的作用。2这两种抑制剂都能抑制所有检测的激动剂诱导的血小板α IIb β 3活化。然而,这些抑制剂并不抑制蛋白磷酸化或细胞内钙离子浓度的增加,这些结果进一步支持了我们的假设,即NCX参与了细胞内的共同步骤,通过α IIb β 3的out信号传导。我们描述了一个日本的Glanzmann血小板无力症的变异体,其血小板表达正常量的α IIb β 3,并且新发现在α IIb亚基的Cys 146-Cys 167环中的两个氨基酸插入是这种表型的原因。此外,Asp 163是配体结合功能的关键残基。关于由外向内信号传导,我们发现α IIb β 3拮抗剂可以分为两组,第一组拮抗剂可以诱导LIBS(配体诱导的结合位点),而在组II中,拮抗剂可以诱导α IIb上的LIBS,但不能诱导β 3上的LIBS。有趣的是,只有I组拮抗剂可以启动α IIb β 3介导的细胞内Ca^<2+>信号传导。我们的研究结果有力地表明β 3 LIBS表达与α IIb β 3介导的细胞内Ca^<2+>信号传导之间存在关联。
英文摘要
In this research project, we have investigated both inside-out and outside-in signaling through the integrin alphaIIbbeta3.Concerning alphaIIbbeta3 activation via inside-out signaling, we have further investigated our hypothesis that Na^+/Ca^<2+> exchanger (NCX) may be involved as a common inside-out signaling.We cloned platelet NCX cDNA and showed that platelet NCX is BD type, while cardiac NCX is BCDEF.Next, employing two unrelated NCX inhibitors, DCB and bepridil, we investigated the role of NCX in platelet activation in detail.Both inhibitors abolished platelet alphaIIbbeta3 activation induced by all agonists examined.However, these inhibitors did not inhibit protein phosphorylation or increase in intracellular calcium concentration.These findings further support our hypothesis that NCX is involves in the common steps of inside-out signaling through alphaIIbbeta3.We characterized a Japanese variant of Glanzmann thrombasthenia whose platelets express normal amounts of alphaIIbbeta3 and newly showed that a two-amino acid insertion in the Cysl46-Cysl67 loop of the alphaIIb subunit is responsible for this phenotype.In addition, Asp163 is a critical residue for ligand binding function.Concerning outside-in signaling, we showed alphaIIbbeta3 antagonists can be divided into two groups.In group I, antagonists can induce LIBS (ligand-induced binding site) on both alphaIIb and beta3, while in group II, antagonists can induce LIBS on alphaIIb, but not on beta3.Interestingly, only group I antagonists can initiate alphaIIbbeta3-mediated intracellular Ca^<2+> signaling.Our findings strongly sugget the association between beta3 LIBS expression and alphaIIbbeta3-mediated intracellular Ca^<2+> signaling.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
Tomiyama Y,Shiraga M,et al: "A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin αIIbβ3." Thrombosis and Haemostasis. 80(5). 735-742 (1998)
Tomiyama Y、Shiraga M 等人:“由整合素 αIIbβ3 的由内而外信号传导缺陷引起的 Glanzmann 血小板无力症样表型。” 血栓形成和止血 80(5)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsumura I,Tomiyama Y,et al: "Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line,CMK,involves transcriptional activation of p21 WAF1/Cip1 by STAT5." Molecular and Cellular Biology. 17(5). 2933-2943 (1997)
Matsumura I、Tomiyama Y 等人:“血小板生成素诱导的人类巨核细胞白血病细胞系 CMK 的分化涉及 STAT5 对 p21 WAF1/Cip1 的转录激活。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Honda S,Tomiyama Y,et al: "Association between ligand-induced conformational change of integrin αIIbβ3 and αIIbβ3 mediated intracellular Ca2_+ signaling." Blood. 92(10). 3675-3683 (1998)
Honda S、Tomiyama Y 等人:“整合素 αIIbβ3 和 αIIbβ3 介导的细胞内 Ca2_+ 信号传导的配体诱导构象变化之间的关联”92(10) 血液。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokota T, et al: "Growth-supporting and death-preventing activities of fibronectin on hematopoletic stem/progenitor cells in and in vivo : structural requirement for fibronectin activites of CS1 and cell-binding domains." Blood. (in press). (1998)
Yokota T 等人:“纤连蛋白在体内和体内对造血干细胞/祖细胞的生长支持和死亡预防活性:CS1 和细胞结合域纤连蛋白活性的结构要求。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 19 条
    Analysis of regulatory molecule in platelets for thrombosis employing CMK cell system
    • 批准号:
      24591422
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      TOMIYAMA Yoshiaki
    • 依托单位:
    Analysis of positive or negative regulatory mechanism for thrombus formation
    • 批准号:
      21591242
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      TOMIYAMA Yoshiaki
    • 依托单位:
    Analysis of regulatory mechanism for α_<IIb>β_3 function by employing newly developed experimental system.
    • 批准号:
      19591109
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      TOMIYAMA Yoshiaki
    • 依托单位:
    Characterization of regulatory proteins for β3 integrins.
    • 批准号:
      15390299
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.77万
    • 财政年份:
      2003
    • 负责人:
      TOMIYAMA Yoshiaki
    • 依托单位:
    国内基金
    海外基金
    血管衰老通过lumican-integrinα2β1通路诱导NVU调控认知障碍的分子机制及干预靶点研究
    • 批准号:
      JCZRLH202602095
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    β1-integrin介导的Warburg效应在TAM耐药乳腺癌中的作用及机制
    • 批准号:
      JCZRLH202600554
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    睡眠剥夺经TNN/Integrin α8β1轴调控巨噬细胞极化促动脉粥样硬化的作用及机制研究
    • 批准号:
      2025JJ60778
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      高嘉慧
    • 依托单位:
    维生素D受体通过抑制Mucin-1/β1-integrin信号通路调节肠道衰老的相关机制研究